Radiopharmaceutical-based Sensing and Monitoring Systems

Publication ID: 24-11857647_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Radiopharmaceutical-based Sensing and Monitoring Systems,” Published Technical Disclosure No. 24-11857647_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857647_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,647.

Summary of the Inventive Concept

The inventive concept leverages the stable radiopharmaceutical composition of tetrofosmin and its pharmaceutically acceptable salts to develop novel sensing and monitoring systems for various industries, including environmental monitoring, agricultural optimization, industrial process control, homeland security, and food safety inspection.

Background and Problem Solved

The original patent disclosed a stable radiopharmaceutical composition of tetrofosmin and its pharmaceutically acceptable salts for diagnostic purposes. However, this technology has broader applications beyond medical diagnostics. The inventive concept addresses the need for more effective and efficient sensing and monitoring systems in various industries, where the unique properties of the radiopharmaceutical composition can be leveraged to provide innovative solutions.

Detailed Description of the Inventive Concept

The inventive concept involves the development of systems, methods, and devices that utilize the radiopharmaceutical composition of tetrofosmin and its pharmaceutically acceptable salts to detect, track, and quantify various parameters in different industries. For example, in environmental monitoring, the radiopharmaceutical composition can be used to detect and track radioactive contaminants in soil and water samples. In agricultural optimization, the composition can be used to measure crop uptake of nutrients and pesticides, allowing for more targeted fertilizer and pesticide application. Similarly, in industrial process control, the composition can be used to monitor and regulate the concentration of radioactive isotopes in industrial processes.

Novelty and Inventive Step

The inventive concept is novel and non-obvious in its application of the radiopharmaceutical composition to entirely new industries and use cases, beyond medical diagnostics. The combination of the radiopharmaceutical composition with sensors, detectors, and other devices to create innovative sensing and monitoring systems is an inventive step that provides a new and useful solution to existing problems in these industries.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different radiopharmaceutical compositions, or the development of miniaturized sensors and detectors that can be integrated into existing systems. Variations of the inventive concept could also include the use of different detection methods, such as spectroscopy or chromatography, to quantify the parameters of interest.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including environmental monitoring, agricultural optimization, industrial process control, homeland security, and food safety inspection. The market for sensing and monitoring systems is growing rapidly, driven by increasing concerns about environmental sustainability, food safety, and national security. The inventive concept offers a new and innovative solution to these industries, with potential for significant revenue growth and market share.

CPC Classifications

SectionClassGroup
A A61 A61K51/0478
A A61 A61K9/19
A A61 A61K31/66
A A61 A61K51/025

Original Patent Information

Patent NumberUS 11,857,647
TitlePharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
Assignee(s)Jubilant Draximage Inc.